0.72 (-%)
As of Nov 21, 2024
Source:
Equillium, Inc is a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need.
Country | United States |
Headquarters | la jolla, california |
Phone Number | (858) 240-1200 |
Industry | manufacturing |
CEO | Bruce D. Steel |
Website | www.equilliumbio.com |